Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study
In a placebo-controlled study, propafenone efficacy and safety for pharmaceutical cardioversion in atrial fibrillation (AF) paroxysms were studied. The study included 50 patients aged 28-69 years (mean age 53,9+9,7), with AF paroxysms lasting for less than 48 hours. Participants were randomized to p...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Articolo |
| Lingua: | russo |
| Pubblicazione: |
«FIRMA «SILICEA» LLC
2005-12-01
|
| Serie: | Российский кардиологический журнал |
| Soggetti: | |
| Accesso online: | https://russjcardiol.elpub.ru/jour/article/view/2343 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Lascia un commento!